Adds Private Placement Expertise to Firm’s Investment Banking Franchise
Thomas Bassinger Joins Leerink Swann
<0> Leerink Swann617-918-4850orSard Verbinnen & Co212-687-8080 </0>
Leading healthcare investment bank Leerink Swann today announced that Thomas Bassinger has recently joined the Firm’s Investment Banking group as a Managing Director, reporting to James Boylan, Head of Investment Banking. Mr. Bassinger will focus on private capital market advisory opportunities as well as advancing strategic relationships with corporate and venture capital clients.
Mr. Bassinger brings 20 years of investment banking, private equity, and strategy consulting experience across multiple industries, including healthcare and technology, to Leerink Swann. He joins the Firm from Rockport Venture Partners, a private placement specialist firm serving life science clients that he co-founded in 2001, where he helped raise over $750M in private equity capital for more than 35 venture-backed companies. In the course of his career, Mr. Bassinger has also co-founded and held senior executive positions in two high-growth, venture backed companies and played a key role in raising over $60 million in private equity for those organizations.
James Boylan, Senior Managing Director and Head of Investment Banking at Leerink Swann, said: “Tom’s proven track record of identifying, building and financing successful companies will be a valuable asset to Leerink Swann and its clients. Tom’s experience and network of strong relationships with both corporate and private capital sources in the medical technology and life sciences sectors will enhance our franchise and our ability to serve our clients’ growing needs. We welcome him to the Firm and look forward to his contributions.”
Thomas Bassinger said: “I am very pleased to join the investment banking team at Leerink Swann and am excited to bring my experience and relationships to the firm. Leerink is a leader in healthcare investment banking advisory and public capital markets and I look forward to advancing the private capital markets business to that level.”
Mr. Bassinger will be based in Boston.
Founded in 1995, Leerink Swann is recognized as a leading healthcare investment bank to a broad range of institutional, life sciences and corporate clients that are positioned to shape the future of healthcare. Leerink Swann's deep domain knowledge provides its clients thoroughly researched insights and perspectives that enable them to make well-informed investment and business decisions. All of its services are enhanced by the expertise of its proprietary MEDACorp network. MEDACorp’s physicians, researchers and healthcare professionals provide insights into cutting-edge advances in healthcare. Guided by expert strategy and insight, we offer investment banking, merger and acquisition services, institutional sales and trading, equity research and consulting services. Leerink Swann is a member of FINRA/SIPC. For more information, visit .